| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Istituto di Endocrinologia (D.P., V.R., D.E., A.B., A.A.S.) and Istituto di Patologia Generale ed Oncologia (C.A., G.A.P.), Seconda Università di Napoli, 80131 Naples, Italy
Address all correspondence and requests for reprints to: Antonio A. Sinisi, M.D., Istituto di Endocrinologia, Seconda Università di Napoli, Building 16, Via Pansini 5, 80131 Naples, Italy. E-mail: antonio.sinisi{at}unina2.it
The aim of this study was to investigate the expression of estrogen
receptor (ER) ß and
genes in normal (N) and malignant (C) primary
cultures of human prostate epithelial cells (PEC) and fibroblasts (PFC)
and in the prostate tissue donors. Both ERß and ER
messenger
ribonucleic acids were found by RT-PCR analysis in six NPECs and normal
prostate tissues and in only one of six CPECs and in the
respective cancer tissue donor. The other five CPECs and related
cancer tissue donors and all normal and cancer PFCs expressed ER
messenger ribonucleic acid alone. Immunoblot analysis, using a
polyclonal anti-ERß (C-terminal) antibody, demonstrated ERß protein
in all NPEC lysates and in one of the six CPECs. ER
protein was
expressed in both NPECs and CPECs when a polyclonal antibody directed
against the ER
N-terminal domain was used. In contrast, ER
protein was not detected in two of the six CPEC lysates when ER
C-terminal monoclonal antibodies were used. Using a set of primers
designed to amplify the region from exons 68, RT-PCR analysis
demonstrated the absence of the expected transcript in these cells. The
present study shows that the ERß gene is expressed together with
ER
in normal prostates and NPECs, whereas it is barely detectable in
prostate cancer and CPECs. Moreover, in some CPECs, the ER
gene may
be transcribed in a changed protein, resulting from the expression of a
deletion variant. Together, these data suggest that prostate malignancy
is associated with a potential disorder of ER-mediated pathways.
This article has been cited by other articles:
![]() |
S. R. Setlur, K. D. Mertz, Y. Hoshida, F. Demichelis, M. Lupien, S. Perner, A. Sboner, Y. Pawitan, O. Andren, L. A. Johnson, et al. Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer J Natl Cancer Inst, June 4, 2008; 100(11): 815 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K M Ho, J. Nanda, K. E Chapman, and F. K Habib Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen J. Endocrinol., June 1, 2008; 197(3): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chen, P. Kraft, P. Bretsky, S. Ketkar, D. J. Hunter, D. Albanes, D. Altshuler, G. Andriole, C. D. Berg, H. Boeing, et al. Sequence Variants of Estrogen Receptor {beta} and Risk of Prostate Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1973 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stettner, S. Kaulfuss, P. Burfeind, S. Schweyer, A. Strauss, R.-H. Ringert, and P. Thelen The relevance of estrogen receptor-{beta} expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment Mol. Cancer Ther., October 1, 2007; 6(10): 2626 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P Risbridger, S. J Ellem, and S. J McPherson Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling J. Mol. Endocrinol., September 1, 2007; 39(3): 183 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-C. Li, P. R. Carroll, and R. Dahiya Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Selva, O. M. Tirado, N. Toran, C. A. Suarez-Quian, J. Reventos, and F. Munell Estrogen Receptor {beta} Expression and Apoptosis of Spermatocytes of Mice Overexpressing a Rat Androgen-Binding Protein Transgene Biol Reprod, November 1, 2004; 71(5): 1461 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Bardin, N Boulle, G Lazennec, F Vignon, and P Pujol Loss of ER{beta} expression as a common step in estrogen-dependent tumor progression Endocr. Relat. Cancer, September 1, 2004; 11(3): 537 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Imamov, A. Morani, G.-J. Shim, Y. Omoto, C. Thulin-Andersson, M. Warner, and J.-A. Gustafsson Estrogen receptor {beta} regulates epithelial cellular differentiation in the mouse ventral prostate PNAS, June 22, 2004; 101(25): 9375 - 9380. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Tirado, D. M. Selva, N. Toran, C. A. Suarez-Quian, M. Jansen, D. P. McDonnell, J. Reventos, and F. Munell Increased Expression of Estrogen Receptor {beta} in Pachytene Spermatocytes After Short-Term Methoxyacetic Acid Administration J Androl, January 1, 2004; 25(1): 84 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pais, I. Leav, K.-M. Lau, Z. Jiang, and S.-M. Ho Estrogen Receptor-{beta} Expression in Human Testicular Germ Cell Tumors Clin. Cancer Res., October 1, 2003; 9(12): 4475 - 4482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Liu, C. Albanese, C. M. Anderson, K. Hilty, P. Webb, R. M. Uht, R. H. Price Jr., R. G. Pestell, and P. J. Kushner Opposing Action of Estrogen Receptors alpha and beta on Cyclin D1 Gene Expression J. Biol. Chem., June 28, 2002; 277(27): 24353 - 24360. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Lobenhofer, L. Bennett, P. L. Cable, L. Li, P. R. Bushel, and C. A. Afshari Regulation of DNA Replication Fork Genes by 17{beta}-Estradiol Mol. Endocrinol., June 1, 2002; 16(6): 1215 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kuwajerwala, E. Cifuentes, S. Gautam, M. Menon, E. R. Barrack, and G. P. V. Reddy Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis Cancer Res., May 1, 2002; 62(9): 2488 - 2492. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |